Position in PAHC
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$773,786
+$198,144 QoQ
Shares Held
13,990
-9.2% QoQ
Ownership
0.034%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PAHC Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Horizon Investments, LLC holds $36,074,962 across 11 Drug Manufacturers - Specialty & Generic names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
23,364 | $12,659,316 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
71,090 | $11,981,508 | |
| 3 | HLN |
Haleon plc
|
274,831 | $2,564,173 | |
| 4 | VTRS |
Viatris Inc
|
125,321 | $1,990,097 | |
| 5 | ZTS |
Zoetis Inc.
|
24,833 | $1,784,499 | |
| 6 | TEVA |
Teva Pharmaceutical Industries Ltd
|
45,561 | $1,543,606 | |
| 7 | INDV |
Indivior Pharmaceuticals, Inc.
|
25,390 | $1,041,751 | |
| 8 | ANIP |
Ani Pharmaceuticals Inc
|
9,779 | $809,505 |
All Filings in PAHC
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $773,786 | 13,990 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $575,642 | 15,408 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $584,647 | 14,450 | Shares | Sole | 2025-11-14 | |
| No filing history on record for this holder in this stock. | ||||||